DementiaDASI-KNCT07180719
Effectiveness of a Dementia Anti-Stigma Intervention in Rural Kenya
A study testing Dementia anti stigma intervention in people with Dementia, run by Africa Institute of Mental and Brain Health (AFRIMEB) at 1 site in Kenya.
Trial summary
Stigma underlies many health disparities in Kenya, and dementia-related stigma is no different. Preliminary evidence highlights the short-term benefits of a dementia anti-stigma intervention in Kenya. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Dementia
- What is being tested?
- Dementia anti stigma intervention
- Type of treatment
- Injection or infusion, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 184 participants
- Where
- 1 siteKenya
- Study dates
- 8 Sep 2025to 28 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Residents of Mbooni Sub county
- Aged 18 years and above
- Able to speak the local language (Kamba)
- Have capacity to consent
Who cannot join
- Non residents of Mbooni Sub county
- Less than 18 years
- Do not speak the local language
- Have no capacity to consent
Trial locations and contacts
1 site in 1 country.
About this study
Stigma underlies many health disparities in Kenya, and dementia-related stigma is no different. Preliminary evidence highlights the short-term benefits of a dementia anti-stigma intervention in Kenya. The study aims to ascertain the long-term effectiveness of a locally developed dementia anti stigma intervention in order to establish a community resource that will improve dementia understanding, reduce stigma and improve health behaviours.
In AIM 1, the investigators will assess what public stigma towards people with dementia and their carers looks like in Kenya, through a survey (600). Individual interviews with 20 members of the general public who completed the survey will be conducted to explore what stigmatizing beliefs are held and why they form. Triangulation techniques will then be used to integrate quantitative and qualitative data. Reflecting on AIM 1 findings, the investigators will engage 20 key stakeholders to refine an existing anti-stigma intervention, to better target culturally specific misconceptions and negative beliefs about dementia (AIM2). In AIM 3, the investigators will determine the effectiveness of the intervention among members of the general public (n=184), through a stepped wedge cluster randomized trial (SWT).
Read the detailed description
The overall aim of this research is to refine and evaluate a dementia stigma reduction intervention tailored to meet the needs of people in Kenya, in preparation for future implementation and adoption within existing policies.
This will be achieved through the following three specific aims. i) AIM 1: To adapt dementia-related knowledge and attitudes tools and develop a representative dementia stigma profile of the general public in Kenya.
ii) AIM 2: To refine an existing anti-stigma intervention to better target culturally specific misconceptions and negative beliefs about dementia.
iii) AIM 3: To determine the effectiveness of the anti-stigma intervention through a stepped wedge cluster randomized trial (SWT) among members of the general public.
Study site is in Makueni County in rural Kenya AIM 1: Adapting a dementia-related knowledge and attitudes tools and developing a representative dementia stigma profile of the general public in Kenya A survey of 600 adults (18 years and older) will be conducted in Makueni County, a rural setting in Kenya. Individuals in rural communities have higher rates of dementia, experience more health disparities and additional challenges with cultural belief systems, and utilization of care compared to their urban counterparts. Participants will be recruited from three geographically defined areas served by six Community Health Workers (CHWs), and ensure a diverse demographic profile based on age, sex and socio-economic status. The three geographically selected rural areas are representative of other rural regions in Kenya due to their similar settings. Participants will complete measures of knowledge (Dementia Knowledge Assessment Scale (DKAS)) and attitudes (Dementia Attitudes Scale (DAS)). DKAS is a reliable and valid tool for assessing dementia knowledge across a range of participants including members of the general public. It has been used among older adults in Africa. DAS is based on the tripartite model of attitude, has been validated for members of the general public and has a high Cronbach's alpha coefficient ranging from 0.83 to 0.85. To ensure that the measures are suitable for use within Kenya, they will undergo cross-cultural adaptation (forward and backward translations will be conducted, inconsistencies checked, and then pilot tested (n=24 general public members). Up to twenty individual interviews will also be held with a convenient sample of members of the general public who completed the survey to better explore what stigmatizing beliefs are held in the communities and why they form.
Recruitment and approach: Members of the general public (n=24 for piloting the study tools and procedures) and (n=600 participants who will be recruited for the main study), aged 18 years and above will be recruited by the CHWs. Households will be approached (i.e., door knocking) upon a convenience basis in the first instance, within geographic regions that the CHWs serve. CHWs will ensure that there is equal representation based on age, sex and socioeconomic status. CHWs will be familiar with the demographics of participants that reside in the local community. All participants will provide either written/thumb print informed consent. The research team will liaise with the CHWs on a weekly basis to reflect on the recruitment progress, but also to identify underrepresented groups. Door knocking benefits from minimizing sources of bias that might occur through other channels (e.g., social media), who reflect certain demographics. The team will however be vigilant that door knocking during the day may lead to an under-representation of working population (e.g., younger, males). In instances within a household where an underrepresented group resides but not present during the initial visit, CHWs will reorganize the visit for a time and date convenient for the potential participant. Guided by the need to achieve thematic saturation, up to 20 members of the general public who completed the survey will also be identified by CHWs through convenience sampling based on their availability, to better explore what stigmatizing beliefs are held in the communities and why they form.
Analysis plan and sample size: Descriptive data will be reported to identify misconceptions and common beliefs within the sample. Regression models will be developed to identify what factors are associated with stigma. To detect a small effect size (f2=0.04) and enter 20 predictors in the model (Power =0.8, alpha = 0.05), accounting for 10% missing data, a sample size of 600 is required. Inductive thematic analysis will be used for the qualitative interviews. Participants will be recruited until thematic saturation is achieved (i.e., until no new themes are inductively identified). Thematic saturation typically occurs between 9 and 17 participants. Triangulation techniques will be used to integrate quantitative and qualitative data.
AIM 2: Refining an existing anti-stigma intervention to better target culturally-specific misconceptions and negative beliefs about dementia. A consortium of the 20 key stakeholders (people with dementia, carers, clinicians, policy makers, academicians and researchers) will be gathered to review the summary report comprising of AIM 1 findings, which will help to identify stigma drivers and target common culturally specific misconceptions and negative beliefs about dementia. Their distribution will be purposive, based on the relevance of stakeholders to the research objectives. This will be discussed alongside the existing intervention to identify any gaps, or whether further refinement of the content is required. The intervention includes four sessions that promote: (i) understanding of dementia, (ii) demystifying myths and misconceptions, (iii) empathetic connections using videos of people with dementia and carers (virtual social contact) and (iv) social inclusion through a case vignette and discussions.
Recruitment: From the list of 20 stakeholders, persons with lived experience will be recruited from Alzheimer's Dementia Organization, Kenya. The investigators will draw on their established networks of collaborators to identify the other stakeholders for the refinement process.
AIM 3: Determining the effectiveness of the anti-stigma intervention through a stepped wedge cluster randomized trial (SWT) among members of the general public This will involve sequential delivery of the intervention to six community-level groups from one site at a time, until all the three sites are exposed to the intervention (n=184). Using participants surveyed in AIM 1, six randomly selected community- level groups consisting of 10-12 members from each of the three geographically defined areas (sites) will be randomly allocated to start on one of three dates (three months apart). Randomization to receive the intervention will be conducted by a blinded independent researcher. Participants will be blinded to allocation while the research assistant will be blinded to the schedule of intervention delivery. Following the listing of the 600 assessed participants, sites will be block randomized into six community-level groups (clusters), then randomly ordered to receive the intervention. Cluster randomization will reduce contamination before the intervention phase, expected to be seen at an individual level. Although all groups will start with a three-month "control condition", six groups from each site will receive the intervention after every three months. With the three-month interval, the rollout program is expected to take about 12 months. The SWT design ensures that all clusters receive the intervention rather than entirely denying benefits to control groups, since there is evidence that the proposed intervention has a short-term positive effect in a context that lacks implementation of evidence-based dementia anti-stigma interventions. Stigma-related outcome data will therefore be collected at baseline (three months before being exposed to the four-session group awareness program), switch points (rollout period during which the clusters will cross over from the control phase), 6- and 12-months post two-week intervention.
Recruitment and retention: Members of the general public (n=184) will be selected from the participants identified in AIM 1. As such, all participants will be aged 18 years and older, able to speak Kamba and have capacity to consent. All participants will have been given the option to participate in the anti-stigma intervention in AIM 1. If there are more than 184 participants (from AIM 1) who have consented to be contacted about the anti-stigma intervention, all potential participants will be randomly listed within each village site. Then from this list, six sets of 10-12 members will be randomly selected and randomly allocated to start on one of three dates (three months apart).
- Conditions
- Dementia
- Being tested
- Dementia anti stigma intervention
- Keywords
- Dementia, Anti stigma, Intervention, Stepped Wedge Cluster Randomized Trial
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dementia anti stigma interventionBehavioural
The intervention is a train-a-trainer programme contextually developed, for delivery (via demonstrations and role-plays) by lay providers such as community health workers. It includes four sessions that promote: (i) understanding of dementia, (ii) demystifying myths and misconceptions, (iii) empathetic connections using videos of people with dementia and carers (virtual social contact) and (iv) social inclusion through a case vignette and discussions. It is delivered bi-weekly in a group setting and each session ranges between 1.5 to 2 hours.
| Study group | Role | What they receive |
|---|---|---|
| Control (Pre-Intervention Phase) | No intervention | Participants are assessed before they receive the dementia anti-stigma intervention. They continue with usual community experiences and do not receive any intervention activities during this time. Outcomes collected reflect baseline knowledge and attitudes related to dementia in the absence of the intervention. |
| Post-Intervention Phase | Other | Participants are assessed after receiving the dementia anti-stigma intervention, which consists of four structured sessions facilitated by trained community health promoters (CHPs). The sessions focus on improving dementia knowledge, reducing stigma, and promoting supportive attitudes toward people with dementia and their families. Outcomes collected reflect changes in dementia knowledge and attitudes following the intervention. Receives: Behavioral: Dementia anti stigma intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Dementia attitudes (measured by the Dementia Attitudes Scale (DAS))
Dementia attitudes will be assessed using the Dementia Attitudes Scale (DAS), a validated tool that measures participants' comfort and perceptions when interacting with people with dementia. Scores on the DAS range from 20 to 140, with higher scores indicating more positive attitudes.
Measured: Assessments will be collected at baseline during enrollment of participants, then every 3 months up until 6 months after switch points of the intervention.
Change in Dementia knowledge (measured by the Dementia Knowledge Assessment Scale (DKAS))
Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS), which evaluates knowledge across domains such as causes, symptoms, risk factors, and care of people with dementia. Scores on the DKAS range from 0 to 50, with higher scores reflecting greater knowledge.
Measured: Assessments will be collected at baseline during enrollment of participants, then every 3 months up until 6 months after switch points of the intervention.
Secondary outcomes (2)
Intervention acceptability
Acceptability of the intervention will be assessed through self-reported responses where participants will be asked about their satisfaction, perceived usefulness, and willingness to continue or repeat participation in the dementia anti-stigma sessions. Outcomes will be reported as the proportion of participants indicating that they found the intervention acceptable and would be willing to continue or engage in similar sessions in the future.
Measured: Immediately post-intervention (within 2 weeks after completion of the 4-session program).
Change in Dementia engagement (Behavior)
This will be assessed through self-reported responses where participants will be asked about their willingness to interact with, support, and include people with dementia in community life. Outcomes will be reported as the proportion of participants providing affirmative responses.
Measured: From baseline during enrollment of participants, then every 3 months up until 6 months after switch points of the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2025
- Study start8 Sep 2025
- Primary completion28 Jun 2027 (estimated)
- Study completion28 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 184 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Africa Institute of Mental and Brain Health (AFRIMEB)
- Sponsor type
- University, hospital or other
- Collaborators
- Alzheimer's Association
- Responsible party
- Sponsor
- Investigators
- Christine Musyimi, PhD, Principal investigator, Africa Institute of Mental and Brain Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07180719
- Sponsor's protocol ID
- MUSERC/01424/24
- Acronym
- DASI-K
- Status last verified
- Oct 2026
- First submitted
- 5 Sep 2025
- Last updated
- 28 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a Dementia Anti-Stigma Intervention in Rural Kenya
- ClinicalTrials.gov ID
- NCT07180719
- Acronym / sponsor ID
- DASI-K / MUSERC/01424/24
- Conditions
- Dementia
- Keywords
- Dementia, Anti stigma, Intervention, Stepped Wedge Cluster Randomized Trial
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 184 participants (estimated)
- Lead sponsor
- Africa Institute of Mental and Brain Health (AFRIMEB)University, hospital or other
- Collaborators
- Alzheimer's Association
- Study start
- 8 Sep 2025 (actual)
- Primary completion
- 28 Jun 2027 (estimated)
- Study completion
- 28 Jun 2027 (estimated)
- First posted
- 18 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Stigma underlies many health disparities in Kenya, and dementia-related stigma is no different. Preliminary evidence highlights the short-term benefits of a dementia anti-stigma intervention in Kenya. The study aims to ascertain the long-term effectiveness of a locally developed dementia anti stigma intervention in order to establish a community resource that will improve dementia understanding, reduce stigma and improve health behaviours.
In AIM 1, the investigators will assess what public stigma towards people with dementia and their carers looks like in Kenya, through a survey (600). Individual interviews with 20 members of the general public who completed the survey will be conducted to explore what stigmatizing beliefs are held and why they form. Triangulation techniques will then be used to integrate quantitative and qualitative data. Reflecting on AIM 1 findings, the investigators will engage 20 key stakeholders to refine an existing anti-stigma intervention, to better target culturally specific misconceptions and negative beliefs about dementia (AIM2). In AIM 3, the investigators will determine the effectiveness of the intervention among members of the general public (n=184), through a stepped wedge cluster randomized trial (SWT).
Detailed description
The overall aim of this research is to refine and evaluate a dementia stigma reduction intervention tailored to meet the needs of people in Kenya, in preparation for future implementation and adoption within existing policies.
This will be achieved through the following three specific aims. i) AIM 1: To adapt dementia-related knowledge and attitudes tools and develop a representative dementia stigma profile of the general public in Kenya.
ii) AIM 2: To refine an existing anti-stigma intervention to better target culturally specific misconceptions and negative beliefs about dementia.
iii) AIM 3: To determine the effectiveness of the anti-stigma intervention through a stepped wedge cluster randomized trial (SWT) among members of the general public.
Study site is in Makueni County in rural Kenya AIM 1: Adapting a dementia-related knowledge and attitudes tools and developing a representative dementia stigma profile of the general public in Kenya A survey of 600 adults (18 years and older) will be conducted in Makueni County, a rural setting in Kenya. Individuals in rural communities have higher rates of dementia, experience more health disparities and additional challenges with cultural belief systems, and utilization of care compared to their urban counterparts. Participants will be recruited from three geographically defined areas served by six Community Health Workers (CHWs), and ensure a diverse demographic profile based on age, sex and socio-economic status. The three geographically selected rural areas are representative of other rural regions in Kenya due to their similar settings. Participants will complete measures of knowledge (Dementia Knowledge Assessment Scale (DKAS)) and attitudes (Dementia Attitudes Scale (DAS)). DKAS is a reliable and valid tool for assessing dementia knowledge across a range of participants including members of the general public. It has been used among older adults in Africa. DAS is based on the tripartite model of attitude, has been validated for members of the general public and has a high Cronbach's alpha coefficient ranging from 0.83 to 0.85. To ensure that the measures are suitable for use within Kenya, they will undergo cross-cultural adaptation (forward and backward translations will be conducted, inconsistencies checked, and then pilot tested (n=24 general public members). Up to twenty individual interviews will also be held with a convenient sample of members of the general public who completed the survey to better explore what stigmatizing beliefs are held in the communities and why they form.
Recruitment and approach: Members of the general public (n=24 for piloting the study tools and procedures) and (n=600 participants who will be recruited for the main study), aged 18 years and above will be recruited by the CHWs. Households will be approached (i.e., door knocking) upon a convenience basis in the first instance, within geographic regions that the CHWs serve. CHWs will ensure that there is equal representation based on age, sex and socioeconomic status. CHWs will be familiar with the demographics of participants that reside in the local community. All participants will provide either written/thumb print informed consent. The research team will liaise with the CHWs on a weekly basis to reflect on the recruitment progress, but also to identify underrepresented groups. Door knocking benefits from minimizing sources of bias that might occur through other channels (e.g., social media), who reflect certain demographics. The team will however be vigilant that door knocking during the day may lead to an under-representation of working population (e.g., younger, males). In instances within a household where an underrepresented group resides but not present during the initial visit, CHWs will reorganize the visit for a time and date convenient for the potential participant. Guided by the need to achieve thematic saturation, up to 20 members of the general public who completed the survey will also be identified by CHWs through convenience sampling based on their availability, to better explore what stigmatizing beliefs are held in the communities and why they form.
Analysis plan and sample size: Descriptive data will be reported to identify misconceptions and common beliefs within the sample. Regression models will be developed to identify what factors are associated with stigma. To detect a small effect size (f2=0.04) and enter 20 predictors in the model (Power =0.8, alpha = 0.05), accounting for 10% missing data, a sample size of 600 is required. Inductive thematic analysis will be used for the qualitative interviews. Participants will be recruited until thematic saturation is achieved (i.e., until no new themes are inductively identified). Thematic saturation typically occurs between 9 and 17 participants. Triangulation techniques will be used to integrate quantitative and qualitative data.
AIM 2: Refining an existing anti-stigma intervention to better target culturally-specific misconceptions and negative beliefs about dementia. A consortium of the 20 key stakeholders (people with dementia, carers, clinicians, policy makers, academicians and researchers) will be gathered to review the summary report comprising of AIM 1 findings, which will help to identify stigma drivers and target common culturally specific misconceptions and negative beliefs about dementia. Their distribution will be purposive, based on the relevance of stakeholders to the research objectives. This will be discussed alongside the existing intervention to identify any gaps, or whether further refinement of the content is required. The intervention includes four sessions that promote: (i) understanding of dementia, (ii) demystifying myths and misconceptions, (iii) empathetic connections using videos of people with dementia and carers (virtual social contact) and (iv) social inclusion through a case vignette and discussions.
Recruitment: From the list of 20 stakeholders, persons with lived experience will be recruited from Alzheimer's Dementia Organization, Kenya. The investigators will draw on their established networks of collaborators to identify the other stakeholders for the refinement process.
AIM 3: Determining the effectiveness of the anti-stigma intervention through a stepped wedge cluster randomized trial (SWT) among members of the general public This will involve sequential delivery of the intervention to six community-level groups from one site at a time, until all the three sites are exposed to the intervention (n=184). Using participants surveyed in AIM 1, six randomly selected community- level groups consisting of 10-12 members from each of the three geographically defined areas (sites) will be randomly allocated to start on one of three dates (three months apart). Randomization to receive the intervention will be conducted by a blinded independent researcher. Participants will be blinded to allocation while the research assistant will be blinded to the schedule of intervention delivery. Following the listing of the 600 assessed participants, sites will be block randomized into six community-level groups (clusters), then randomly ordered to receive the intervention. Cluster randomization will reduce contamination before the intervention phase, expected to be seen at an individual level. Although all groups will start with a three-month "control condition", six groups from each site will receive the intervention after every three months. With the three-month interval, the rollout program is expected to take about 12 months. The SWT design ensures that all clusters receive the intervention rather than entirely denying benefits to control groups, since there is evidence that the proposed intervention has a short-term positive effect in a context that lacks implementation of evidence-based dementia anti-stigma interventions. Stigma-related outcome data will therefore be collected at baseline (three months before being exposed to the four-session group awareness program), switch points (rollout period during which the clusters will cross over from the control phase), 6- and 12-months post two-week intervention.
Recruitment and retention: Members of the general public (n=184) will be selected from the participants identified in AIM 1. As such, all participants will be aged 18 years and older, able to speak Kamba and have capacity to consent. All participants will have been given the option to participate in the anti-stigma intervention in AIM 1. If there are more than 184 participants (from AIM 1) who have consented to be contacted about the anti-stigma intervention, all potential participants will be randomly listed within each village site. Then from this list, six sets of 10-12 members will be randomly selected and randomly allocated to start on one of three dates (three months apart).
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control (Pre-Intervention Phase) | No intervention | –Participants are assessed before they receive the dementia anti-stigma intervention. They continue with usual community experiences and do not receive any intervention activities during this time. Outcomes collected reflect baseline knowledge and attitudes related to dementia in the absence of the intervention. |
| Post-Intervention Phase | Other | Behavioral: Dementia anti stigma interventionParticipants are assessed after receiving the dementia anti-stigma intervention, which consists of four structured sessions facilitated by trained community health promoters (CHPs). The sessions focus on improving dementia knowledge, reducing stigma, and promoting supportive attitudes toward people with dementia and their families. Outcomes collected reflect changes in dementia knowledge and attitudes following the intervention. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Residents of Mbooni Sub county
- Aged 18 years and above
- Able to speak the local language (Kamba)
- Have capacity to consent
Key exclusion criteria (4 listed)
- Non residents of Mbooni Sub county
- Less than 18 years
- Do not speak the local language
- Have no capacity to consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dementia anti stigma interventionThe intervention is a train-a-trainer programme contextually developed, for delivery (via demonstrations and role-plays) by lay providers such as community health workers. It includes four sessions that promote: (i) understanding of dementia, (ii) demystifying myths and misconceptions, (iii) empathetic connections using videos of people with dementia and carers (virtual social contact) and (iv) social inclusion through a case vignette and discussions. It is delivered bi-weekly in a group setting and each session ranges between 1.5 to 2 hours. | Behavioural | Post-Intervention Phase |
Primary outcome
Change in Dementia attitudes (measured by the Dementia Attitudes Scale (DAS))
Time frame: Assessments will be collected at baseline during enrollment of participants, then every 3 months up until 6 months after switch points of the intervention.
Dementia attitudes will be assessed using the Dementia Attitudes Scale (DAS), a validated tool that measures participants' comfort and perceptions when interacting with people with dementia. Scores on the DAS range from 20 to 140, with higher scores indicating more positive attitudes.
Change in Dementia knowledge (measured by the Dementia Knowledge Assessment Scale (DKAS))
Time frame: Assessments will be collected at baseline during enrollment of participants, then every 3 months up until 6 months after switch points of the intervention.
Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS), which evaluates knowledge across domains such as causes, symptoms, risk factors, and care of people with dementia. Scores on the DKAS range from 0 to 50, with higher scores reflecting greater knowledge.
2 secondary outcomes
Intervention acceptability
Time frame: Immediately post-intervention (within 2 weeks after completion of the 4-session program).
Change in Dementia engagement (Behavior)
Time frame: From baseline during enrollment of participants, then every 3 months up until 6 months after switch points of the intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2026.
Related trials for Dementia
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christine Musyimi, PhD principal investigator
Africa Institute of Mental and Brain Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dementia anti stigma intervention in people with Dementia, run by Africa Institute of Mental and Brain Health (AFRIMEB) at 1 site in Kenya.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Dementia attitudes (measured by the Dementia Attitudes Scale (DAS)) (time frame: Assessments will be collected at baseline during enrollment of participants, then every 3 months up until 6 months after switch points of the intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.